This article is more than 5 years old. Information may no longer be current.
Dana-Farber surgical oncology chief to assume ASCO presidency in 2018
Click Here to Manage Email Alerts
Monica M. Bertagnolli, MD, has been elected president of ASCO for the 2018-2019 term.
Bertagnolli — chief of the division of surgical oncology at Dana-Farber/Brigham and Women’s Cancer Center, as well as associate surgeon at Brigham and Women’s Hospital and Dana-Farber Cancer Institute — will assume the presidency in June 2018. She will begin a 1-year term as president-elect this summer.
Bertagnolli, a member of ASCO since 1995, has served on the society’s board of directors and its cancer prevention committee.
“Serving as ASCO president is a tremendous honor for anyone in the field of oncology,” Bertagnolli said in a press release. “Much more importantly, it is an opportunity for me to make a meaningful difference by providing a strong voice in the health care community for those whom I consider to be my particular constituency: clinical and translational researchers, community and academic oncologists participating in clinical research, and surgical oncologists.”